AGE1.CR® technology will be used to produce poultry vaccines

Wednesday, 18 December 2019 00:00 Written by  font size decrease font size decrease font size increase font size increase font size

ProBioGen and Ceva have signed an agreement to exclusively utilize AGE1.CR® technology in the production of poultry vaccines.

The two companies have a long history of working together in research and development.
Experts believe that utilizing this technology has proven its versatility and value in the manufacture of poultry vaccines and will provide many advantages in the production process of these products.
The technology has the potential to deliver vaccine production in large GMP-compatible bioreactors.
Due to its genetic stability, this cell line is an ideal host for producing complementary cell lines, especially in alphavirus and paramyxovirus vectors.
This technology can be used in a wide range of viruses including influenza, rabies, IBDV, turkey rhinostragitis virus (TRT), marker disease virus (MDV), vesicular stomatitis virus (VSV) and turkey herpes virus (HTV). 

Read 198 times
Rate this item
(0 votes)

Who's Online

We have 103 guests and no members online

Hot events

Template Settings


For each color, the params below will give default values
Black Blue Brow Green Cyan


Background Color
Text Color
Layout Style
Select menu
Google Font
Body Font-size
Body Font-family